Emamectin·chlorfenapyr-induced fatal leukoencephalomyelopathy with delayed hyperthermia: insecticide endanger public safety

Xun� Li, Yun Yang, Yajing Zhang, Xuebin Zhang, Na Zhao, Wei YueFrontiers in Neurology 2024 · DOI

TL;DR

This paper reports a rare, fatal case of leukoencephalomyelopathy in a 65-year-old woman following ingestion of the insecticide emamectin-chlorfenapyr. The case highlights the severe neurotoxicity of this pesticide combination, characterized by delayed hyperthermia and extensive white matter damage, underscoring the need for further research into its mechanisms and potential antidotes.

What Problem Does This Paper Address?

The paper addresses the limited understanding of the human toxicity of emamectin-chlorfenapyr, a widely used agricultural insecticide. While chlorfenapyr's mechanism of action and toxicity in animals are known, its progression and specific effects in humans, particularly in combination with emamectin benzoate (EB), remain poorly elucidated. Existing literature on chlorfenapyr poisoning is scarce, and cases involving this specific combination are rare. This study aims to contribute to this knowledge gap by detailing a fatal case, including comprehensive clinical, radiological, and cerebrospinal fluid (CSF) findings, to shed light on the severe neurological consequences and potential immunological responses.

Methods

The study is primarily a case report detailing the clinical presentation, diagnostic workup, and outcome of a single patient. Key methods employed include:

  • Clinical Assessment: Standard neurological examination, vital sign monitoring, and Glasgow Coma Scale (GCS) assessments.
  • Laboratory Tests: Blood tests for creatinine kinase (CK), liver function tests (AST, ALT), complete blood count (CBC), and procalcitonin. Urine toxicology screening for common illicit drugs and benzodiazepines.
  • Neuroimaging: Magnetic Resonance Imaging (MRI) of the brain and spine using a 3.0 T unit, including T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) maps.
  • Cerebrospinal Fluid (CSF) Analysis: Lumbar puncture to obtain CSF for pressure measurement, cell count, biochemical analysis (chloride, glucose, lactate, protein), and next-generation sequencing for pathogen detection.
  • Cytological Smear: Examination of CSF for cellular morphology and aggregation patterns.

The paper also includes a literature review to compare the presented case with previously reported instances of emamectin-chlorfenapyr poisoning.

Datasets

Not discussed in the paper. The study focuses on a single patient's clinical data and a review of existing literature.

Key Insights and Ideas

  • Delayed and Severe Neurotoxicity: The case demonstrates a significant latent period (approximately 9 days) between ingestion and the onset of severe neurological symptoms, followed by rapid deterioration and death. This delayed onset is a critical characteristic of this type of poisoning.
  • Extensive Leukoencephalomyelopathy: MRI revealed diffuse, symmetrical damage to the white matter tracts in both the brain and spinal cord, a finding that is central to the diagnosis of leukoencephalomyelopathy. This widespread damage highlights the systemic neurotoxic potential of the insecticide.
  • Unique CSF Findings: The CSF analysis revealed an abnormal lymphocytic aggregation around proteinaceous material in a "wreath-like" configuration. This is presented as a novel finding in emamectin-chlorfenapyr intoxication and is hypothesized to represent an immunological response to myelin breakdown products.
  • Hyperthermia as a Critical Indicator: Delayed and refractory hyperthermia was a prominent feature, contributing to the patient's fatal outcome. This suggests a disruption of thermoregulation mechanisms.
  • Synergistic Toxicity: The combination of emamectin and chlorfenapyr appears to have a synergistic effect, leading to a more severe and rapidly fatal outcome than might be expected from either agent alone.

Key Results

  • Fatal Outcome: The patient died 19.5 hours after admission due to cardiopulmonary arrest and hyperthermia.
  • Elevated Creatine Kinase: Markedly elevated CK levels (2,406 IU/L) indicated significant muscle damage (rhabdomyolysis).
  • Extensive White Matter Lesions: MRI showed diffuse T2 hyperintensities in the brain's white matter (cerebellum, medulla, pons, midbrain, cerebral peduncles, corpus callosum, parieto-occipital regions) and spinal cord (cervical region and conus medullaris).
  • Abnormal CSF Cytology: CSF revealed a high white blood cell count (5200*10^6/L) with 94% neutrophils and a characteristic lymphocytic aggregation pattern.
  • High Mortality Rate: A literature review indicated a high mortality rate (84.21%) among reported cases of emamectin-chlorfenapyr poisoning, with many deaths occurring within 24 hours of admission.

Limitations and Future Work

Limitations:

  • Unqualified Manufacturer: The exact dosage and formulation of the ingested pesticide were uncertain due to the manufacturer being unqualified and lacking a production permit, making precise dose-response analysis difficult.
  • Limited Tralopyril Data: While chlorfenapyr is metabolized to tralopyril, blood concentration levels of tralopyril were very low at the time of testing, hindering interpretation of its role.
  • Single Case Study: The findings are based on a single case, limiting generalizability.

Future Work:

  • Flow Cytometry in Intoxication: Further research is needed to establish protocols for performing flow cytometry on patients with emamectin-chlorfenapyr intoxication.
  • Immunological Mechanisms: Elucidating the immunological mechanisms underlying the inflammatory response to this pesticide combination is crucial.
  • Antidote Development: Insights from understanding the pathophysiology could lead to the development of new antidotes.
  • Public Health Awareness: The paper implicitly calls for increased awareness of the dangers of these pesticides and the need for better regulation and public health education, especially in regions with high pesticide use.

Summary updated

Abstract

Further research is needed on how to perform flow cytometry in patients with emamectin·chlorfenapyr intoxication, and to elucidate the immunological mechanism underlying the inflammatory response caused by emamectin·chlorfenapyr and provide new insights into antidote development.
BibTeX
@inproceedings{li2024emamectinchlorfenapyr,
  author = {Xun� Li and Yun Yang and Yajing Zhang and Xuebin Zhang and Na Zhao and Wei Yue},
  title = {{Emamectin·chlorfenapyr-induced fatal leukoencephalomyelopathy with delayed hyperthermia: insecticide endanger public safety}},
  booktitle = {Frontiers in Neurology},
  year = {2024},
  doi = {10.3389/fneur.2024.1449728},
}
Figure